Chaudhuri Vaishali, Tayal Ruchi, Nayak Baibaswata, Acharya Subrat Kumar, Panda Subrat Kumar
Department of Pathology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India.
Gastroenterology. 2004 Nov;127(5):1356-71. doi: 10.1053/j.gastro.2004.08.003.
Genome sequence of hepatitis B virus (HBV) from occult chronic infection is scarce. Fifty-six (9.4%) of 591 patients seronegative for hepatitis B surface antigen (HBsAg) with chronic liver disease were positive for HBV DNA. The complete HBV genome from 9 of these patients (S1-S9) and 5 controls positive for HBsAg (SWT.1-SWT.5) were analyzed.
Overlapping genome fragment amplification, cloning, and sequencing was performed on these cases. Functional analysis of surface promoter was conducted using fusion construct.
All patients with occult infection except one (S8) had a low viral titer. Eight patients had infection with genotype A (S1-S5, SWT.1-2, SWT.5) and 6 had infection with genotype D (S6-S9, SWT.3-4). S4 and S5.1 of genotype A had the characteristic nucleotide deletions in core and pre-S1 region seen in genotype D. The major observations in patients with occult HBV infection were as follows: frequent quasispecies variation, deletions in pre-S2/S region affecting the surface promoters (nt 3025-54) and pre-S protein (S3, S5, S6, S8), truncated precore (S6, S8, S7.1) and core (S9) owing to stop signal, alternate start codon for the Polymerase gene (S3, S9), and YMDD mutation (S1, S4, S9) in patients not on antiviral therapy. HBsAg and core proteins could be shown immunohistochemically in 3 of 5 liver biopsy specimens available. The mutant surface promoters (pre-S2 and S) on functional analysis showed alterations in HBsAg expression.
These changes in the regulatory region with possible alterations in the ratio of large and small surface proteins along with other mutations in the genome may decrease the circulating HBsAg level synergistically, making the immunodetection in serum negative.
隐匿性慢性感染的乙型肝炎病毒(HBV)基因组序列稀少。591例慢性肝病患者中,56例(9.4%)乙肝表面抗原(HBsAg)血清学阴性,但HBV DNA呈阳性。对其中9例患者(S1 - S9)的完整HBV基因组以及5例HBsAg阳性对照(SWT.1 - SWT.5)进行了分析。
对这些病例进行重叠基因组片段扩增、克隆及测序。使用融合构建体对表面启动子进行功能分析。
除1例(S8)外,所有隐匿性感染患者的病毒载量均较低。8例患者感染了A型基因型(S1 - S5,SWT.1 - 2,SWT.5),6例感染了D型基因型(S6 - S9,SWT.3 - 4)。A型基因型的S4和S5.1在核心区和前S1区有D型基因型特有的核苷酸缺失。隐匿性HBV感染患者的主要观察结果如下:频繁的准种变异、前S2/S区缺失影响表面启动子(核苷酸3025 - 54)和前S蛋白(S3、S5、S6、S8)、由于终止信号导致的前核心(S6、S8、S7.1)和核心(S9)截短、聚合酶基因的替代起始密码子(S3、S9)以及未接受抗病毒治疗患者中的YMDD突变(S1、S4、S9)。在可用的5例肝活检标本中,有3例通过免疫组织化学方法可显示HBsAg和核心蛋白。功能分析显示,突变的表面启动子(前S2和S)在HBsAg表达方面存在改变。
调控区的这些变化以及大小表面蛋白比例可能的改变,连同基因组中的其他突变,可能协同降低循环中的HBsAg水平,导致血清免疫检测呈阴性。